Trastuzumab Emtansine is a HER2-targeting antibody-drug concatenation (ADC) that can be used in studies related to HER2-positive metastatic breast cancer.
Purity:
>99.0%
CAS Number:
[1018448-65-1]
* VAT and and shipping costs not included. Errors and price changes excepted